Bill Text: GA HB521 | 2009-2010 | Regular Session | Introduced
Bill Title: Serious illness; system of prevention; add certain genetic conditions
Sponsorship: Partisan Bill (Democrat 5)
Status: (Introduced - Dead) 2009-02-25 - House Second Readers [HB521 Detail]
Download: Georgia-2009-HB521-Introduced.html
09 LC 38
0796
House
Bill 521
By:
Representatives Beasley-Teague of the
65th,
Brooks of the
63rd,
Stephenson of the
92nd,
Taylor of the
55th,
and Lucas of the
139th
A
BILL TO BE ENTITLED
AN ACT
AN ACT
To
amend Code Section 31-12-6 of the Official Code of Georgia Annotated, relating
to a system for prevention of serious illness, severe physical or developmental
disability, and death resulting from inherited metabolic and genetic disorders,
so as to add certain genetic conditions to the list of genetic conditions for
which the Department of Community Health has created a system of prevention; to
provide for related matters; to repeal conflicting laws; and for other
purposes.
BE
IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:
SECTION
1.
Code
Section 31-12-6 of the Official Code of Georgia Annotated, relating to a system
for prevention of serious illness, severe physical or developmental disability,
and death resulting from inherited metabolic and genetic disorders, is amended
by revising subsection (a) as follows:
"(a)
The department shall promulgate rules and regulations creating a system for the
prevention of serious illness, severe physical or developmental disability, and
death caused by genetic conditions, such as phenylketonuria, galactosemia,
homocystinuria, maple syrup urine disease, hypothyroidism, congenital adrenal
hyperplasia,
citrullinemia, argininosuccinic acidemia, tyrosinemia type I, isovaleric
acidemia, glutaric acidemia type I, hydroxymethylglutaric aciduria, multiple
carboxylase deficiency, methylmalonic acidemia due to mutase deficiency,
methylmalonic acidemia, 3-methylcrotonyl-CoA carboxylase deficiency, propionic
acidemia, beta-ketothiolase deficiency, medium-chain acyl-CoA dehydrogenase
deficiency, very long-chain acyl-CoA dehydrogenase deficiency, long-chain 3-OH
acyl-CoA dehydrogenase deficiency, trifunctional protein deficiency, carnitine
uptake defect, sickle cell anemia, Hb S/beta-thalassemia, Hb S/C disease,
biotinidase deficiency, cystic fibrosis,
and such other inherited metabolic and genetic disorders as may be identified in
the future to result in serious illness, severe physical or developmental
disability, and death if undiagnosed and untreated. The system shall have five
components: screening newborns for the disorders; retrieving potentially
affected screenees back into the health care system; accomplishing specific
diagnoses; initiating and continuing therapy; and assessing the
program."
SECTION
2.
All
laws and parts of laws in conflict with this Act are repealed.
